Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
33
FDA:10
CANADA:10
NMPA:3
Drug Approvals
Levocetirizine Dihydrochloride
- Product Name
- 盐酸左西替利嗪
- Approval Number
- H20170320
- Approval Date
- May 26, 2017
NMPA
Clinical Trials
No trials found
News
Granules India CEO Dr. K V Sitaram Rao Announces Resignation Effective July 2025
Dr. Kandiraju Venkata Sitaram Rao has resigned from his position as Joint Managing Director and CEO of Granules India Limited, effective July 31, 2025.